삼성서울병원

Ko En

Hematology-Oncology Yoon, Sang Eun M.D

Expertise
Lymphoma, multiple myeloma, Transplantation, CAR-T cell therapy,Hematopoietic stem cell transplantation, Amyloidosis
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

2016~2020 Ph.D. in Medicine Medical school, EWHA Womans University, Seoul, Korea
2008~2012 Master of Science Medical school, EWHA Womans University, Seoul, Korea

Post-Graduate Training

Fellowship   2018~2019 Hematology/Oncology, Samsung Medical Center, Seoul, Korea
2017~2018 Hematology/Oncology, EWHA Womans university hospital, Seoul, Korea
Residency   2013~2017 Hematology/Oncology, EWHA Womans university hospital, Seoul, Korea
Internship   2012~2013 Hematology/Oncology, EWHA Womans university hospital, Seoul, Korea

Professional Appointments

2019~2024 Clinical Instructor Hematology/Oncology, Samsung Medical Center, Seoul, Korea
2024~Present Assistant Professor Hematology/Oncology, Samsung Medical Center, Seoul, Korea

Professional Memberships

2017~Present Member The Korean society of hematology
2013~Present Member The Korean association of internal medicine.

Selected Publications

  • J NEUROIMMUNOL 2021 10.1016/j.jneuroim.2021.577564 Increased proportion of CD20+T cells after rituximab treatment in patient with neuromyelitis optica later diagnosed with lung B-cell lymphoma: A case report Lee1, JK; Kwon, S; Han, JH; Yoon, SE; Kim, BJ; Kang, ES
    View PubMed
  • KOREAN J INTERN MED 2021 10.3904/kjim.2019.367 Real-world data on the survival outcome of patients with newly diagnosed Waldenstrom macroglobulinemia Cho1, JH; Shim, JH; Yoon, SE; Kim, HJ; Kim, SH; Ko, YH; Lee, ST; Kim, K; Kim, WS; Kim, SJ
    View PubMed
  • CANCER MANAG RES 2021 10.2147/CMAR.S309092 Real-World, Single-Center Data for Lenalidomide Plus Rituximab in Relapsed or Refractory Diffuse Large B-Cell Lymphoma and Transformed Follicular Lymphoma Lee1, YP; Hong, JY; Yoon, SE; Cho, J; Shim, JH; Bang, Y; Kim, WS; Kim, SJ
    View PubMed
  • EXP HEMATOL ONCOL 2021 10.1186/s40164-021-00224-3 Comprehensive analysis of clinical, pathological, and genomic characteristics of follicular helper T-cell derived lymphomas Yoon1, SE; Cho, J; Kim, YJ; Ko, YH; Park, WY; Kim, SJ; Kim, WS
    View PubMed
  • FRONT ONCOL 2021 10.3389/fonc.2021.628807 Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma Lee1, B; Lee, H; Cho, J; Yoon, SE; Kim, SJ; Park, WY; Kim, WS; Ko, YH
    View PubMed